ALX Oncology jumps on venture capital fund share purchase
Source: SeekingAlpha
2026-02-04 17:30:34 ET
More on ALX Oncology
- ALX Oncology Holdings Inc. (ALXO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- ALX Oncology Holdings Inc. (ALXO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- ALX Oncology Holdings Inc. 2025 Q3 - Results - Earnings Call Presentation
- ALX Oncology announces pricing of underwritten offering; shares up nearly 15%
- ALX Oncology anticipates $2B–$4B HER2/CD47 breast cancer market opportunity while advancing biomarker-driven strategies
Read the full article on Seeking Alpha
For further details see:
ALX Oncology jumps on venture capital fund share purchase
ALX Oncology Holdings Inc.
NASDAQ: ALXO
ALXO Trading
-9.38% G/L:
$2.03 Last:
296,390 Volume:
$2.21 Open:
ALXO Latest News
February 27, 2026 08:00:00 am
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
ALXO Stock Data
$136,900,453
32,964,545
2.6%
20
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
